DANTRIUM INTRAVENOUS
KNIGHT THERAPEUTICS INC.
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of DANTRIUM INTRAVENOUS in Canada?
Yes. DANTRIUM INTRAVENOUS 20MG has an active shortage reported to Health Canada (last updated October 16, 2026).
Why is DANTRIUM INTRAVENOUS not available?
The reason the manufacturer reported: Disruption of the manufacture of the drug.
When will DANTRIUM INTRAVENOUS be available again?
No estimated resolution date has been reported yet. Follow this page to get an email as soon as the status changes.
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Health Canada classes this as a Tier 3 shortage, its highest-impact category. If you rely on this medication, talk to your pharmacist or care team now rather than waiting for your supply to run low. This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.
DIN
01997572
Strength
20MG
Dosage Form
POWDER FOR SOLUTION
Route
INTRAVENOUS
Active Ingredient
DANTROLENE SODIUM
Tier
Tier 3 — Critical
Last Updated
2026-10-16
Reason for Shortage
Disruption of the manufacture of the drug.
Other Products from KNIGHT THERAPEUTICS INC.
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
DIN 02468735
0.25MG · DIN 02381710
0.5MG · DIN 02381729
DIN 02332450
1G · DIN 02242980
DIN 02505223
400MG · DIN 02245828
30MG · DIN 02296152
DIN 02290308
25MG · DIN 01997602
5MG · DIN 01924516
15MG · DIN 01924567